Skip to main content
OpenTrials

Clinical trial condition

Progesterone Receptor-negative Breast Cancer

Explore clinical trials studying Progesterone Receptor-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

13 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Progesterone Receptor-negative Breast Cancer trial results

Completed

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

NCT01805076

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +10 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
  • Enloe Medical Center Chico, California, United States
View all 179 locations
View Trial Details
Completed

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

NCT00577122

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, San Francisco Comprehensive Cancer Center San Francisco, California, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer

NCT00733408

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +10 more
Locations
  • Anchorage Oncology Centre Anchorage, Alaska, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Yuma Cancer Center Yuma, Arizona, United States
View all 17 locations
View Trial Details
Completed

Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer

NCT00516243

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +9 more
Locations
  • Columbia University Medical Center New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Baylor College of Medicine Houston, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions